Recombinant DNA (rDNA) Technology Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : May 2020 Pages : 150 Category: Biotechnology Report Code : HC0511138

Recombinant DNA (rDNA) Technology Market by Type (Medical, Non-Medical) Application (Biotechnology Companies, Pharmaceuticals) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Recombinant DNA (rDNA) Technology Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Recombinant DNA (rDNA) Technology formed by laboratory methods of genetic recombination (such as molecular cloning) to bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2019 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

    • Amgen Inc
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd
    • GenScript
    • Merck KGaA
    • New England Biolabs
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi

Some of the key questions answered by the report are:

  • What was the market size in 2016 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Recombinant DNA (rDNA) Technology Market, By Type, Estimates and Forecast, 2016-2027 ($Million)

o    Medical

o    Non-Medical

·         Recombinant DNA (rDNA) Technology Market, By Application, Estimates and Forecast, 2016-2027 ($Million)

o    Biotechnology Companies

o    Pharmaceuticals

·         Recombinant DNA (rDNA) Technology Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    Amgen Inc

o    Eli Lilly and Company

o    F. Hoffmann-La Roche Ltd

o    GenScript

o    Merck KGaA

o    New England Biolabs

o    Novartis AG

o    Novo Nordisk A/S

o    Pfizer Inc.

o    Sanofi

·         Recombinant DNA (rDNA) Technology Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Submarine Cables Market, By Country

o    U.S. Submarine Cables Market

o    Canada Submarine Cables Market

o    Mexico Submarine Cables Market

o    Europe

§  Europe Submarine Cables Market, By Country

o    Germany Submarine Cables Market

o    UK Submarine Cables Market

o    France Submarine Cables Market

o    Russia Submarine Cables Market

o    Italy Submarine Cables Market

o    Rest of Europe Submarine Cables Market

o    Asia-Pacific

§  Asia-Pacific Submarine Cables Market, By Country

o    China Submarine Cables Market

o    Japan Submarine Cables Market

o    South Korea Submarine Cables Market

o    India Submarine Cables Market

o    Southeast Asia Submarine Cables Market

o    Rest of Asia-Pacific Submarine Cables Market

o    South America

§  South America Submarine Cables Market

o    Brazil Submarine Cables Market

o    Argentina Submarine Cables Market

o    Columbia Submarine Cables Market

o    Rest of South America Submarine Cables Market

o    Middle East and Africa

§  Middle East and Africa Submarine Cables Market

o    Saudi Arabia Submarine Cables Market

o    UAE Submarine Cables Market

o    Egypt Submarine Cables Market

o    Nigeria Submarine Cables Market

o    South Africa Submarine Cables Market

o    Rest of MEA Submarine Cables Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Recombinant DNA (rDNA) Technology  Market, By Type

5.1.     Introduction

5.2.     Global Recombinant DNA (rDNA) Technology  Revenue and Market Share by Type (2016-2019)

5.2.1.  Global Recombinant DNA (rDNA) Technology  Revenue and Revenue Share by Type (2016-2019)

5.3.     Medical

5.3.1.  Global Medical Revenue and Growth Rate (2016-2019)

5.4.     Non-Medical

5.4.1.  Global Non-Medical Revenue and Growth Rate (2016-2019)

6.       Recombinant DNA (rDNA) Technology  Market, By Applications

6.1.     Introduction

6.2.     Global Recombinant DNA (rDNA) Technology  Revenue and Market Share by Applications (2016-2019)

6.2.1.  Global Recombinant DNA (rDNA) Technology  Revenue and Revenue Share by Applications (2016-2019)

6.3.     Biotechnology Companies

6.3.1.  Global Biotechnology Companies Revenue and Growth Rate (2016-2019)

6.4.     Pharmaceuticals

6.4.1.  Global Pharmaceuticals Revenue and Growth Rate (2016-2019)

7.       Recombinant DNA (rDNA) Technology  Market, By Region

7.1.     Introduction

7.2.     Global Recombinant DNA (rDNA) Technology  Revenue and Market Share by Regions

7.2.1.  Global Recombinant DNA (rDNA) Technology  Revenue by Regions (2016-2019)

7.3.     North America Recombinant DNA (rDNA) Technology  by Countries

7.3.1.  North America Recombinant DNA (rDNA) Technology  Revenue and Growth Rate (2016-2019)

7.3.2.  North America Recombinant DNA (rDNA) Technology  Revenue (Million USD) by Countries (2016-2019)

7.3.3.  United States

7.3.3.1.  United States Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.4.  Canada

7.3.4.1.  Canada Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.5.  Mexico

7.3.5.1.  Mexico Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.     Europe Recombinant DNA (rDNA) Technology  by Countries

7.4.1.  Europe Recombinant DNA (rDNA) Technology  Revenue and Growth Rate (2016-2019)

7.4.2.  Europe Recombinant DNA (rDNA) Technology  Revenue (Million USD) by Countries (2016-2019)

7.4.3.  Germany

7.4.3.1.  Germany Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.4.  France

7.4.4.1.  France Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.5.  UK

7.4.5.1.  UK Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.6.  Russia

7.4.6.1.  Russia Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.7.  Italy

7.4.7.1.  Italy Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.     Asia-Pacific Recombinant DNA (rDNA) Technology  by Countries

7.5.1.  Asia-Pacific Recombinant DNA (rDNA) Technology  Revenue and Growth Rate (2016-2019)

7.5.2.  Asia-Pacific Recombinant DNA (rDNA) Technology  Revenue (Million USD) by Countries (2016-2019)

7.5.3.  China

7.5.3.1.  China Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.4.  Japan

7.5.4.1.  Japan Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.5.  Korea

7.5.5.1.  Korea Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.6.  India

7.5.6.1.  India Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.     South America Recombinant DNA (rDNA) Technology  by Countries

7.6.1.  South America Recombinant DNA (rDNA) Technology  Revenue and Growth Rate (2016-2019)

7.6.2.  South America Recombinant DNA (rDNA) Technology  Revenue (Million USD) by Countries (2016-2019)

7.6.3.  Brazil

7.6.3.1.  Brazil Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.4.  Argentina

7.6.4.1.  Argentina Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.5.  Columbia

7.6.5.1.  Columbia Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.     Middle East and Africa Recombinant DNA (rDNA) Technology  by Countries

7.7.1.  Middle East and Africa Recombinant DNA (rDNA) Technology  Revenue and Growth Rate (2016-2019)

7.7.2.  Middle East and Africa Recombinant DNA (rDNA) Technology  Revenue (Million USD) by Countries (2016-2019)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.5.  Egypt

7.7.5.1.  Egypt Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.7.  South Africa

7.7.7.1.  South Africa Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.8.  Turkey

7.7.8.1.  Turkey Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2016-2019)

8.       Company Profiles

8.1.     Amgen Inc

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Eli Lilly and Company

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     F. Hoffmann-La Roche Ltd

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     GenScript

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Merck KGaA

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     New England Biolabs

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Novartis AG

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Novo Nordisk A/S

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Pfizer Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Sanofi

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.1.     Global Recombinant DNA (rDNA) Technology  Revenue (Millions USD) and Growth Rate (2019-2027)

9.2.     Recombinant DNA (rDNA) Technology  Market Forecast by Regions (2019-2027)

9.2.1.  North America Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.1.1.  United States Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.1.2.  Canada Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.1.3.  Mexico Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.  Europe Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.1.  Germany Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.2.  France Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.3.  UK Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.4.  Russia Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.5.  Italy Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.2.6.  Rest of Europe Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.  Asia-Pacific Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.1.  China Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.2.  Japan Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.3.  Korea Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.4.  India Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.5.  Southeast Asia Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.3.6.  Rest of Asia-Pacific Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.4.  South America Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.4.1.  Brazil Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.4.2.  Argentina Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.4.3.  Columbia Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.4.4.  Rest of South America Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.  Middle East and Africa Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.1.  Saudi Arabia Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.2.  United Arab Emirates Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.3.  Egypt Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.4.  Nigeria Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.5.  South Africa Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.6.  Turkey Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.2.5.7.  Rest of Middle East and Africa Recombinant DNA (rDNA) Technology  Market Forecast (2019-2027)

9.3.     Recombinant DNA (rDNA) Technology  Market Forecast by Type (2019-2027)

9.3.1.  Recombinant DNA (rDNA) Technology  Forecast by Type (2019-2027)

9.3.2.  Recombinant DNA (rDNA) Technology  Market Share Forecast by Type (2019-2027)

9.4.     Recombinant DNA (rDNA) Technology  Market Forecast by Applications (2019-2027)

9.4.1.  Recombinant DNA (rDNA) Technology  Forecast by Applications (2019-2027)

9.4.2.  Recombinant DNA (rDNA) Technology  Market Share Forecast by Applications (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Recombinant DNA (rDNA) Technology Revenue and Revenue Share by Type (2016-2019)
Figure Global Medical Revenue and Growth Rate (2016-2019)
Figure Global Non-Medical Revenue and Growth Rate (2016-2019)
Table Global Recombinant DNA (rDNA) Technology Revenue and Revenue Share by Applications (2016-2019)
Figure Global Biotechnology Companies Revenue and Growth Rate (2016-2019)
Figure Global Pharmaceuticals Revenue and Growth Rate (2016-2019)
Table Global Recombinant DNA (rDNA) Technology Revenue by Regions (2016-2019)
Figure North America Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure North America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2019)
Figure North America Recombinant DNA (rDNA) Technology by Countries (2016-2019)
Figure North America Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2016-2019)
Figure United States Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure United States Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Canada Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Mexico Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Europe Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2019)
Figure Europe Recombinant DNA (rDNA) Technology by Countries (2016-2019)
Figure Europe Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2016-2019)
Figure Germany Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Germany Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure France Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure UK Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Russia Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Italy Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Rest of Europe Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Asia-Pacific Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Recombinant DNA (rDNA) Technology by Countries (2016-2019)
Figure Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2016-2019)
Figure China Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure China Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Japan Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Korea Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure India Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Southeast Asia Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure South America Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2019)
Figure South America Recombinant DNA (rDNA) Technology by Countries (2016-2019)
Figure South America Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Brazil Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Argentina Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Columbia Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Rest of South America Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Middle East and Africa Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Recombinant DNA (rDNA) Technology by Countries (2016-2019)
Figure Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Saudi Arabia Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure United Arab Emirates Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Egypt Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Nigeria Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure South Africa Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Turkey Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Recombinant DNA (rDNA) Technology Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2016-2019)
Table Amgen Inc Recombinant DNA (rDNA) Technology Financial Overview
Table Eli Lilly and Company Recombinant DNA (rDNA) Technology Financial Overview
Table F. Hoffmann-La Roche Ltd Recombinant DNA (rDNA) Technology Financial Overview
Table GenScript Recombinant DNA (rDNA) Technology Financial Overview
Table Merck KGaA Recombinant DNA (rDNA) Technology Financial Overview
Table New England Biolabs Recombinant DNA (rDNA) Technology Financial Overview
Table Novartis AG Recombinant DNA (rDNA) Technology Financial Overview
Table Novo Nordisk A/S Recombinant DNA (rDNA) Technology Financial Overview
Table Pfizer Inc. Recombinant DNA (rDNA) Technology Financial Overview
Table Sanofi Recombinant DNA (rDNA) Technology Financial Overview
Figure Global Recombinant DNA (rDNA) Technology Revenue (Millions USD) and Growth Rate (2019-2027)
Table Recombinant DNA (rDNA) Technology Market Forecast by Regions (2019-2027)
Figure North America Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure United States Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Canada Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Mexico Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Europe Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Germany Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure France Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure UK Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Russia Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Italy Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Rest of Europe Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Asia-Pacific Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure China Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Japan Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Korea Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure India Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Southeast Asia Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure South America Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Brazil Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Argentina Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Columbia Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Rest of South America Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Middle East and Africa Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Saudi Arabia Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure United Arab Emirates Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Egypt Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Nigeria Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure South Africa Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Turkey Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Recombinant DNA (rDNA) Technology Market Forecast (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Forecast by Type (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Market Share Forecast by Type (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Forecast by Type (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Forecast by Applications (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Market Share Forecast by Applications (2019-2027)
Figure Global Recombinant DNA (rDNA) Technology Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*